|
|
NEW ON THE MARKET
|
|
Natalizumab (TYSABRI) for multiple sclerosis: renewed clinical testing needed
Renewed approval for the neuroleptic sertindole (SERDOLECT): incomprehensible
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Intensive insulin therapy for critically ill patients?
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Vasopressin analogue desmopressin (e.g. MINIRIN) for enuresis nocturna?
|
|
|
IN BRIEF
|
|
Warning on allegedly herbal remedies for impotence
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Olfactory and taste disturbance with roxithromycin (e.g. RULID) and other macrolides
|
|
|
SIDE EFFECTS
|
|
Liver damage due to the phytoestrogen containing cimicifuga preparations (e.g. REMIFEMIN)
Priapism associated with withdrawal from sustained-release methylphenidate (e.g. CONCERTA)
Increase of fatal strokes with the osteoporosis-drug raloxifene (EVISTA)
|
|